Login
E-mail
Password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Indici
  3. Svizzera
  4. Swiss Exchange
  5. SMI
  6. Notizie
  7. Altre lingue
    SMI   CH0009980894

SMI

(SMI)
RiassuntoQuotazioniGraficiNotizieDerivatiHeatmapComposizione 
RiassuntoTutte le notizieAltre lingueNotizie dei componenti dell'indice
Notizie in altre lingue su SMI
15:50UBS: Fined by Hong Kong Regulatory Body Over Breaches
14:59Swisscom-Internet-Zugang in der ganzen Schweiz unterbrochen
13:13SGS: New EU Commission Guidance Document on Decorative Products and Product for..
13:03NOVARTIS: announces lift of partial clinical trial hold and plans to initiate a..
12:57SWISSCOM: accès Internet interrompu dans toute la Suisse
12:55UBS: Hong Kong regulator fines UBS $1.5 million for compliance breaches
12:51Swisscom-Internet-Zugang zeitweise in der ganzen Schweiz unterbrochen
12:46Novartis Gets FDA Approval to Proceed With Trials for Muscular Atrophy Treatm..
11:58NOVARTIS: Says FDA Lifts Partial Hold on Clinical Trial of Spinal Muscular Atro..
09:47Novartis-Aktien fester nach FDA-Entscheid zu gestoppter Zolgensma-Studie
09:35NOVARTIS: levée de suspension partielle pour des essais
09:25LONZA: Board Members Divest Shares for $2 Million
09:19ROCHE: examen prioritaire obtenu en cancer du poumon
07:48NOVARTIS: to Launch New Study of Neuromuscular Disease Drug After US FDA Lifts ..
07:41ROCHE: Tecentriq Accepted For Priority Review in US For Lung Cancer
07:36Novartis erhält grünes Licht für Fortsetzung von intrathekaler SMA-Studie
07:36Novartis lance une étude clinique sur OAV-101 contre l'amyotrophie spinale
07:17ROCHE: U.S. FDA gives priority review to Roche's Tecentriq lung cancer drug
07:15PRESS RELEASE: Novartis announces lift of partial -2-
07:15PRESS RELEASE: Novartis announces lift of partial clinical trial hold and plans..
07:15Novartis announces lift of partial clinical trial hold and plans to initiate ..
07:15Novartis Announces Lift of Partial Clinical Trial Hold and Plans to Initiate ..
07:01ROCHE: US FDA grants Priority Review to Roche's Tecentriq as adjuvant treatment..
07:01ROCHE: FDA Grants Priority Review to Genentech's Tecentriq as Adjuvant Treatmen..
07:00PRESS RELEASE: US FDA grants Priority Review to -2-
07:00PRESS RELEASE: US FDA grants Priority Review to Roche's Tecentriq as adjuvant t..
07:00US FDA Grants Priority Review to Roche’s Tecentriq as Adjuvant Treatment for ..
06:10MARKET CHATTER: Credit Suisse May Raise Junior Banker Salaries
05:34ROCHE: Carrick Therapeutics to Study Combination Treatment in Metastatic Breast..
05:24MARKET CHATTER: Credit Suisse Issues $3.8 Billion Bonds
02/08UBS: Announces Completion of the Index Succession for Two ETNs
02/08Aktien Schweiz schließen auf Rekordhoch - Finanzwerte fest
02/08Carrick Therapeutics Announces Collaboration with Roche to Evaluate Novel Sam..
02/08Credit Suisse holt Fintech-Banker von HSBC
02/08Credit Suisse Appoints Wolfram Peters as Head of Risk in its Asset Management..
02/08MOVES-Credit Suisse poaches HSBC's fintech banker to revamp FIG franchise - m..
02/08Neuer Bafin-Chef Branson will Aufsichtsbehörde von 'Weltklasse'
02/08Polizei räumt Blockade von Klimaaktivisten vor Banken in Zürich
02/08SWISSCOM: Ready for the world of work
02/08ROCHE: la FDA étend le domaine d'application d'un anti-Covid
02/08Holcim-Aktien nach Gerüchten über Verkauf der Aktivitäten in Brasilien gesuch..
02/08CREDIT SUISSE: Police clear climate activists from Zurich financial zone
02/08ROCHE: FDA expands authorized use of REGEN-COV (casirivimab and imdevimab)
02/08NESTLE S A: S&P Affirms Ratings, Stable Outlook on Nestlé
02/08MARKET CHATTER: Holcim in Talks to Sell Brazilian Assets for Up to $1.5 Billion
02/08CREDIT SUISSE: Chairman Boosts Stake With $1.1 Million Stock Buy
01/08CSN Cimentos intéressé par des activités d'Holcim au Brésil
01/08CSN Cimentos an Holcim-Aktivitäten in Brasilien interessiert
01/08CSN, Apodi, Mizu, Votorantim, Intercement Reportedly bid for LafargeHolcim As..
01/08Presseschau vom Wochenende 31 (31. Juli/1. August)
31/07CS: Viele Firmen dürften Rückzahlungsfrist für Coronanotkredite nicht ausreizen
30/07CREDIT SUISSE: chairman doubles down with $1 million stock purchase
30/07CREDIT SUISSE: Horta-Osortio achète des actions pour 1 million de francs
30/07NESTLE S A: reports half-year results for 2021, raises full-year organic sales ..
30/07Aktien Schweiz gehen etwas fester ins Wochenende
30/07CS-Verwaltungsratspräsident kauft Aktien im Wert von rund 1 Mio Franken
30/07Swiss Re renoue avec les profits au 1er semestre
30/07Holcim accroît ses ambitions à mi-parcours
30/07++ Analysen des Tages von Dow Jones Newswires (30.07.2021) +++
30/07SGS: Durabilité des vêtements, pourquoi est-ce important ?
30/07Swiss Re erzielt im Halbjahr einen Milliardengewinn
30/07ROCHE: Invitation to Roche's Virtual Pharma Day - Tuesday, 14th September 2021
30/07HOLCIM: LafargeHolcim stellt ehrgeizigere Ziele in Aussicht
30/07Swiss Re Ag Reports Earnings Results for the Half Year Ended June 30, 2021
30/07Bauboom beschert Holcim Gewinnsprung
30/07L'euro monte encore avant l'inflation américaine
30/07Holcim Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
30/07NACH MILLIARDENGEWINN: Swiss Re erwartet hohe Kosten durch Sturzflut
30/07CYBERSECURITY: Enabling a More Interconnected World
30/07CREDIT SUISSE: Hires Allianz Exec To New Chief Risk Role In Asset Management
30/07ANALYSE/Credit Suisse muss mutige Veränderungen vornehmen
30/07Swiss Re-Aktie trotz hohem Halbjahresgewinn unter Druck
30/07HOLCIM: ups operating profit view with stimulus due to kick in
30/07MARKT: Holcim nach Semesterzahlen leicht im Minus
30/07Holcim aux avant-postes, après un semestre éclatant
1  2  3  4  5  6  7  8  9  10Pross.
Grafico SMI
Durata : Periodo :
SMI: grafico analisi tecnica SMI | MarketScreener
Grafico a schermo intero
Trend analisi tecnica SMI
Breve TermineMedio TermineLungo Termine
TrendRialzistaRialzistaRialzista
Migliori e Peggiori SMI
ABB LTD33.435 Prezzo stimato in tempo reale.1.13%
LONZA GROUP AG717.9 Prezzo stimato in tempo reale.0.49%
SWISS LIFE HOLDING AG471.8 Prezzo stimato in tempo reale.0.32%
PARTNERS GROUP HOLDING AG1565.25 Prezzo stimato in tempo reale.0.27%
ROCHE HOLDING AG352.475 Prezzo stimato in tempo reale.0.16%
UBS GROUP AG15.015 Prezzo stimato in tempo reale.-0.46%
NESTLÉ S.A.114.27 Prezzo stimato in tempo reale.-0.51%
COMPAGNIE FINANCIÈRE RICHEMONT SA117.25 Prezzo stimato in tempo reale.-0.68%
SWISS RE LTD81.96 Prezzo stimato in tempo reale.-0.80%
ALCON INC.66.44 Prezzo stimato in tempo reale.-0.89%
Heatmap :